Innovstone Therapeutics Ltd. has described aromatic heterocyclic compounds acting as ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1) inhibitors potentially useful for the ...
Innovstone Therapeutics Ltd. has synthesized aromatic heterocyclic compounds acting as leucine-rich repeat kinase 2 (LRRK2; Dardarin) inhibitors reported to be useful for the treatment of Parkinson’s ...
A group of 29 reference anthelmintics (21 aromatic-heterocyclic and 8 organophosphate compounds) were evaluated for antiparasitic activity against 4 mouse helminths (Nematospiroides dubius, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback